Barry Canton, 10% Owner at Ginkgo Bioworks Holdings, Inc. (DNA), sold 150,600 shares at $1.62 ($248K) on 2023-10-04, disclosed to the SEC on 2023-10-06.
Scheduled sale ($248k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.62 | 37,650 | $61K | 24.6% |
| 2 | $1.62 | 37,650 | $61K | 24.6% |
| 3 | $1.67 | 37,650 | $63K | 25.4% |
| 4 | $1.67 | 37,650 | $63K | 25.4% |
| Total | $1.65 avg | 150,600 | $248K | 100% |
| Filing → |
| DNA | SELL | 2023-12-22 | $133K | — | Filing → |
| DNA | SELL | 2023-12-15 | $173K | — | Filing → |
| DNA | SELL | 2023-12-08 | $99K | — | Filing → |